Literature DB >> 2547112

The cytotoxic effects of estradiol-17 beta, catecholestradiols and methoxyestradiols on dividing MCF-7 and HeLa cells.

J C Seegers1, M L Aveling, C H Van Aswegen, M Cross, F Koch, W S Joubert.   

Abstract

In this study the cytotoxic effects of high concentrations (greater than or equal to 1 x 10(-6) M) of estradiol-17 beta (E2), 2-/4-hydroxyestradiol-17 beta (2-/4-OHE2) and 2-/3-/4-methoxyestradiol-17 beta (2-/3-/4-MeOE2) were determined on dividing MCF-7 and HeLa cells. The 2-MeOE2 metabolite followed by 2-OHE2 and E2 (in this order) proved to be extremely toxic to dividing MCF-7 and HeLa cells. The cytotoxic effect on these cells comprised uneven chromosome distribution. Indirect immunofluorescent studies, in which monoclonal anti-alpha-tubulin antibodies were used, showed that these compounds (2-MeOE2 greater than 2-OHE2 greater than E2) at high concentrations caused abnormal and fragmented polar formations as well as disorientated microtubule arrangement in the dividing MCF-7 and HeLa cells. The 4-OHE2 and 3-/4-MeOE2 metabolites had little or no cytotoxic effects on dividing cells. The large number of abnormal metaphases seen in HeLa cells exposed to 2-MeOE2 suggested that this metabolite may be the ultimate cytotoxic compound. The reduction in the number of HeLa cells with abnormal metaphase configurations after exposure to 2-OHE2 plus quinalizarin (an inhibitor of catechol-O-methyltransferase) indicated that the production of 2-MeOE2 is necessary for the formation of abnormal spindles in metaphase. Quinalizarin treatment in the presence of 2-MeOE2 had no effect on the large number of abnormal metaphases. We therefore conclude that neither E2 nor 2-OHE2, but a high concentration of 2-MeOE2 is responsible for abnormal spindle formation. In additional experiments the number of normal and abnormal dividing HeLa cells were greatly reduced when simultaneously exposed to E2 and 2-/4-hydroxylase-inhibitor alpha-naphthoflavone.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2547112     DOI: 10.1016/0022-4731(89)90455-x

Source DB:  PubMed          Journal:  J Steroid Biochem        ISSN: 0022-4731            Impact factor:   4.292


  13 in total

Review 1.  Enzymatic regulation of estradiol-17 beta concentrations in human breast cancer cells.

Authors:  J B Adams
Journal:  Breast Cancer Res Treat       Date:  1992-03       Impact factor: 4.872

2.  Whole flaxseed diet alters estrogen metabolism to promote 2-methoxtestradiol-induced apoptosis in hen ovarian cancer.

Authors:  Anushka Dikshit; Karen Hales; Dale Buchanan Hales
Journal:  J Nutr Biochem       Date:  2017-01-23       Impact factor: 6.048

3.  2-Methoxyestradiol, an endogenous mammalian metabolite, inhibits tubulin polymerization by interacting at the colchicine site.

Authors:  R J D'Amato; C M Lin; E Flynn; J Folkman; E Hamel
Journal:  Proc Natl Acad Sci U S A       Date:  1994-04-26       Impact factor: 11.205

4.  Proliferation and differentiation of prepubertal mouse vaginal epithelial cells in vitro and the specificity of estrogen-induced growth retardation.

Authors:  P S Tsai; F D Uchima; S T Hamamoto; H A Bern
Journal:  In Vitro Cell Dev Biol       Date:  1991-06

5.  Hepatic veno-occlusive disease as a result of a traditional remedy: confirmation of toxic pyrrolizidine alkaloids as the cause, using an in vitro technique.

Authors:  M Zuckerman; V Steenkamp; M J Stewart
Journal:  J Clin Pathol       Date:  2002-09       Impact factor: 3.411

6.  Genetic polymorphisms in human SULT1A1 and UGT1A1 genes associate with breast tumor characteristics: a case-series study.

Authors:  Ekaterina G Shatalova; Susan E Walther; Olga O Favorova; Timothy R Rebbeck; Rebecca L Blanchard
Journal:  Breast Cancer Res       Date:  2005-09-21       Impact factor: 6.466

7.  Pharmacokinetics and efficacy of 2-methoxyoestradiol and 2-methoxyoestradiol-bis-sulphamate in vivo in rodents.

Authors:  C R Ireson; S K Chander; A Purohit; S Perera; S P Newman; D Parish; M P Leese; A C Smith; B V L Potter; M J Reed
Journal:  Br J Cancer       Date:  2004-02-23       Impact factor: 7.640

8.  Prevention of mammary carcinogenesis by short-term estrogen and progestin treatments.

Authors:  Lakshmanaswamy Rajkumar; Raphael C Guzman; Jason Yang; Gudmundur Thordarson; Frank Talamantes; Satyabrata Nandi
Journal:  Breast Cancer Res       Date:  2003-11-11       Impact factor: 6.466

9.  In vivo inhibition of angiogenesis by sulphamoylated derivatives of 2-methoxyoestradiol.

Authors:  S K Chander; P A Foster; M P Leese; S P Newman; B V L Potter; A Purohit; M J Reed
Journal:  Br J Cancer       Date:  2007-04-10       Impact factor: 7.640

10.  A molecular understanding of D-homoestrone-induced G2/M cell cycle arrest in HeLa human cervical carcinoma cells.

Authors:  Renáta Minorics; Noémi Bózsity; Judit Molnár; János Wölfling; Erzsébet Mernyák; Gyula Schneider; Imre Ocsovszki; István Zupkó
Journal:  J Cell Mol Med       Date:  2015-07-31       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.